YD Bio Limited Ordinary Shares YDES · SEC Filings

website

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical...

Price6.71

Market Cap481.27 M

Float2.92 M

CountryTW

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Apr 30, 2026

News

TYPE

HEADLINE

FILED AT

6-K

YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026

Aug 31, 2026

6-K

YD Bio Launches Physician-Partnership Nutraceutical Initiative in Taiwan

Aug 11, 2026

6-K

YD Bio Limited Reports Full Year 2025 Financial Results and 2026 Strategic Outlook

Apr 30, 2026

6-K

YD Bio Limited Establishes Taiwan-U.S. Regulatory Platform via Strategic Alliance with YC Biotech

Feb 26, 2026

6-K

YD Bio Limited to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd.

Jan 30, 2026

6-K

YD Bio Limited Announces Board Appointments and Regains Compliance with Nasdaq Audit Committee Requirements

Jan 20, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

UPDATE TO PRIOR PROSPECTUS | Shares: 73,143,525

Aug 31, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 73,143,525

Aug 11, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 76,061,934

Feb 27, 2026

424B3

UPDATE TO PRIOR PROSPECTUS | Shares: 76,061,934

Feb 5, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 70,542,500 | Share price: $11.50 | Warrants amount: 11,625,000

Nov 17, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION

Jul 18, 2025

Registrations

TYPE

HEADLINE

FILED AT

POS AM

SHARE RESALE REGISTRATION | Shares: 73,143,525

May 26, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 2, 2026

F-1/A

SHARE RESALE REGISTRATION | Shares amount: 659,136,934 | Share price: $11.50 | Warrants amount: 11,625,000 | Warrants exercise price: $11.50

Oct 24, 2025

F-1

SHARE RESALE REGISTRATION

Sep 23, 2025

20FR12B

Form 20FR12B - Registration of securities [Section 12(b)]

Sep 5, 2025

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Aug 20, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Chang Kochi (Reporting)

Oct 6, 2026

Lu Shao-Ta (Reporting)

Oct 6, 2026

Shen Ethan PhD (Reporting)

Sep 16, 2026

Shen Ethan PhD (Reporting)

Sep 10, 2026

Shen Ethan PhD (Reporting)

Sep 8, 2026

Lu Shao-Ta (Reporting)

Jul 1, 2026

Other

TYPE

HEADLINE

FILED AT